0000950170-23-013531.txt : 20230419
0000950170-23-013531.hdr.sgml : 20230419
20230419173305
ACCESSION NUMBER: 0000950170-23-013531
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230417
FILED AS OF DATE: 20230419
DATE AS OF CHANGE: 20230419
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Blanchfield Paul
CENTRAL INDEX KEY: 0001801395
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36569
FILM NUMBER: 23830881
MAIL ADDRESS:
STREET 1: C/O LANTHEUS HOLDINGS, INC.
STREET 2: 331
CITY: NORTH BILLERICA
STATE: MA
ZIP: 01862
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Lantheus Holdings, Inc.
CENTRAL INDEX KEY: 0001521036
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 352318913
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 331 TREBLE COVE ROAD
CITY: NORTH BILLERICA
STATE: MA
ZIP: 01862
BUSINESS PHONE: 978 671-8001
MAIL ADDRESS:
STREET 1: 331 TREBLE COVE ROAD
CITY: NORTH BILLERICA
STATE: MA
ZIP: 01862
FORMER COMPANY:
FORMER CONFORMED NAME: Lantheus MI Holdings, Inc.
DATE OF NAME CHANGE: 20110517
4
1
ownership.xml
4
X0407
4
2023-04-17
0001521036
Lantheus Holdings, Inc.
LNTH
0001801395
Blanchfield Paul
C/O LANTHEUS HOLDINGS, INC.
201 BURLINGTON ROAD, SOUTH BUILDING
BEDFORD
MA
01730
false
true
false
false
See Remarks
false
Common Stock
2023-04-17
4
A
false
8464
0
A
95028
D
Stock Option (right to buy)
89.16
2023-04-17
4
A
false
5025
0
A
2033-04-16
Common Stock
5025
5025
D
Consists of 2,821 restricted stock units that vest in equal installments over a three-year period and 5,643 Total Shareholder Return performance-based restricted stock units ("PSUs") that cliff vest following a three-year performance period. The amount of PSUs included in this Report reflects the target award, however the ultimate award size can range from 0% to 200% of the target based on the actual performance achieved at the end of the performance period.
Includes 221 shares acquired under the LNTH employee stock purchase plan on March 13, 2023.
The option vests in three equal annual installments beginning on April 17, 2024.
President
/s/ Daniel M. Niedzwiecki, attorney-in-fact
2023-04-19